Aureate Healthcare Pvt Ltd
Dasafav 50 Tablet Patient Guide
Dasafav 50 Tablet is a medication containing dasatinib, an oral kinase inhibitor. It is manufactured by Aureate Healthcare Pvt Ltd. This guide will provide you with essential information about the uses, mechanism of action, dosage, potential side effects, precautions, and frequently asked questions.
Dasafav 50 Tablet is used for general health purposes, including the treatment of certain types of cancer. It works by blocking specific proteins that contribute to the growth and spread of cancer cells.
Dasatinib exerts its effects by inhibiting multiple tyrosine kinases, including BCR-ABL, c-KIT, EPHA2, and PDGFRβ. This action helps to prevent the proliferation and survival of cancer cells, ultimately leading to their death.
To ensure the safe and effective use of Dasafav 50 Tablet, follow these dosage instructions:
Like all medications, Dasafav 50 Tablet can cause side effects. Common side effects may include:
In rare cases, more serious side effects can occur, such as:
Before taking Dasafav 50 Tablet, inform your doctor about:
A: Dasafav 50 Tablet can cause serious side effects, including bleeding or bruising, infection, kidney damage, and liver damage. Inform your doctor immediately if you experience any of these symptoms.
A: Before taking Dasafav 50 Tablet with other medications, consult your doctor. Some medications may interact with dasatinib, leading to adverse effects.
A: The duration of treatment with Dasafav 50 Tablet depends on your individual condition and response to the medication. Your doctor will determine the appropriate treatment duration.
By following the guidelines outlined in this patient guide, you can safely and effectively use Dasafav 50 Tablet to manage your condition. If you have any questions or concerns, consult your doctor or pharmacist.
pregnancy
Consult Doctor
alcohol
Caution
driving
Caution